The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced it received CE mark approval in Europe for its ...

Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an ...

Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

Though late to the party compared to other industry leaders, Abbott joins a pulsed field ablation market poised for ...

St. David's in Austin is the first in country to use new dual catheter to fix heart flutter and AFib at the same time.

Medtronic announced today that it brought its Affera mapping and ablation system into clinical use for the first time in Sweden.

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced business updates and ...

Using a temperature-controlled ablation system for ventricular tachycardia is safe and effective, says new study.

Abbott's Volt PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillationPulsed field ablation - or PFA - uses high energy electrical ...

Thursday announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib).